Biobank Cohort Forum
Webinar series organised by Biobank Sweden and Cohorts.se.
Coming up next:
Title TBD
Speaker: TBD
More information to come…
Date: TBD
Time: 12:00-13:00 (Central European Time)
About: The webinar is free of charge and will be live-streamed.
Use this link: TBD
Or register below to receive a standing invitation to the Biobank Cohort Forum!
Previous webinars
EP10: Measuring circulating tumour DNA in blood samples – biobanking requirements
In this episode, principal researcher Johan Lindberg will share his experiences of analysing circulating tumour DNA (ctDNA) in blood samples, a method which is highly interesting for early tumour detection although still under development. An additional issue is that analysis of ctDNA typically requires 8-12 ml of plasma while most biobanks are constantly moving towards smaller volumes.
Speaker
Johan Lindberg, Principal Researcher, Karolinska Institutet
EP9: What is Biobank Sweden doing to reduce the legal and administrative hurdles in biobank research?
In this episode, Katarina Trygg, Legal advisor at Uppsala University discusses the outcome of the previous workshop series ”Sitter det käppar i kohortforskningens hjul” regarding administrative hurdles and obstacles within biobank research. The presentation includes results from on-going discussions with authorities and other legal advisors as well as the next steps forward.
Speaker
Katarina Trygg, Legal adviser, Uppsala University
EP8: Is storage on a dry matrix a viable option in clinical research and an alternative to discarding sample collections?
In this episode, we focus on the potential of filter paper for storing samples. What kind of analyses are possible with filter paper samples, and what kind of analyses are not? Is filter paper an alternative when sample collections otherwise need to be discarded?
Speaker
Ulf Gyllensten, Professor, Uppsala University
EP7: The Norwegian Mother, Father and Child Cohort Study (MoBa) – unique research opportunities
In this episode, professor Ole Andreassen discusses MoBa and topics such as overcoming practical biobank issues, the need for collaborations between university/health care and register-holding authorities, as well as the study design from both a legal and scientific perspective.
Speaker
Ole Andreassen, professor at the Centre for Precision Psychiatry, Institute of Clinical Medicine, University of Oslo
EP6: Creating an Environment for Sustainable Biobanking – lessons from the Netherlands
In this episode, Rogier van der Stijl will present the approach, results and impact of this BBMRI.nl project, including what lessons we can take with us regarding sustainability of Swedish biobank cohorts.
Speaker
Rogier van der Stijl, Project manager, Cohort and Biobank Coordination Hub, University Medical Center Groningen, Netherlands
EP5: The European Health Data Space and Biobanking – are there conflicting goals in relation to GDPR?
The establishment of a European Health Data Space (EHDS) is a key priority of the European Commission and its European strategy for data 2019-2025.
In this episode, Dr. Michaela TH. Mayrhofer discusses EHDS in relation to biobanking practices, data protection, secondary use of health data for research, innovation, stakeholder involvement and altruism in research.
Speaker
Dr. Michaela TH. Mayrhofer, Head of ELSI Services & Research, BBMRI-ERIC
EP4: Proteomics at Population Scale: Early findings from the UK Biobank Pharma Proteomics Project
In our fourth episode, we focus on early findings from the UK Biobank Pharma Proteomics Project and the possibilities for proteomics research using large population cohorts.
Speakers
Cynthia Lawley, Director of Population Health at Olink
Dr. Chris D. Whelan, Director, Data Science, Neuropsychiatry at Johnson & Johnson
EP3: The case for federated analysis: a DataSHIELD perspective
In this episode, Dr. Becca Wilson presents and discusses DataSHIELD, an analytic platform comprising a suite of open-source software and a range of disclosure control methodologies to facilitate the co-analysis of individual-level data from several studies, without the need of sharing data outside of the host institution.
Speaker
Dr. Becca Wilson, University of Liverpool
EP2: Harmonizing research data: what should we keep in mind?
In this episode of the Biobank Cohort Forum, Dr. Isabel Fortier who is leading the Maelstrom Research Platform shares some of her knowledge regarding harmonization of research data.
Speaker
Dr. Isabel Fortier, Research Institute of the McGill University Health Centre
EP1: The new Swedish National Biobank Registry:
What’s there? Can any human study now be turned into a biobank study?
In this episode of the Biobank Cohort Forum, Hanna Fransson presents the Swedish National Biobank Registry (SBR) and Dr. Andrea Ganna shares some of his experiences of biobank research in Finland.
Speakers
Hanna Fransson, Regional Biobank Centre (RBC) Mellansverige
Dr. Andrea Ganna, Institute for Molecular Medicine Finland, University of Helsinki